HOME - Clinical cases - Oral Hygiene & Prevention
 
 
23 September 2026

Propolis-containing formulations in caries prevention - a systematic review and meta-analysis.


This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.

Abstract

OBJECTIVES: This systematic review and meta-analysis evaluated the clinical efficacy of propolis-containing formulations (PCFs) in preventing dental caries (PROSPERO: CRD420251246707).

METHODS: This study adhered to the PRISMA 2020 guidelines. Systematic database searches were conducted (December 11, 2025) without language or date restrictions. Eligible studies were randomized clinical trials (RCTs) assessing PCFs (dentifrices, mouthwashes, tablets, etc.) for caries-related outcomes compared with negative control or chlorhexidine-containing formulations (CHX). Standardized mean differences (SMD) were calculated using random-effects models. Meta-analyses were conducted for the outcomes plaque index (PI) and microbial counts in saliva or biofilm (MC). RoB 2 tool and GRADE were used as quality assessment tools.

RESULTS: Of 1,919 identified records, 45 studies were included. Direct caries-related outcomes (caries indices) were rarely assessed and unsuitable for meta-analysis. PCFs significantly reduced PI compared with negative control (SMD[95% CI]: -1.11 [-1.52, -0.70], p < 0.01) and showed no significant difference compared with CHX (0.46 [-0.04, 0.95], p = 0.07). Similar patterns were observed for MC (PFCs vs. negative control (-1.45 [-2.43, -0.48], p = 0.004; PFCs vs. CHX: 0.38 [-0.11, 0.87], p = 0.13). Certainty of evidence was very low due to high risk of bias, inconsistency and indirectness.

CONCLUSION: Propolis-containing formulations may reduce plaque indices and oral microbial counts, suggesting a potential role in caries prevention. However, high-quality studies assessing direct caries outcomes are needed to properly address the research question.

CLINICAL RELEVANCE: Propolis-containing formulations are widely available and well accepted by patients. Clinicians may consider them as adjuncts to oral biofilm control but the evidence directly supporting their clinical efficacy in caries prevention is still not well established.

Key takeaway

Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.

Introduction from full text

This systematic review of randomized clinical trials aimed to evaluate the available evidence regarding the efficacy of propolis-based mouthwash on dental plaque and gingival inflammation.

Peer-reviewed source

Luciana Pisenti Berto, Richard Johannes Wierichs, Letícia Oba Sakae, Samira Helena Niemeyer, Thiago Saads Carvalho

Clinical oral investigations. 2026

DOI: 10.1038/s41415-025-9012-9

PMID: 42593545

PubMed: https://pubmed.ncbi.nlm.nih.gov/42593545/

Image: Diana Polekhina (Unsplash)

Related articles

This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate...


This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate...


This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from Journal of dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...


Read more

New zygomatic implant system brings MegaGen’s BLUEDIAMOND engineering, XPEED® surface technology, and flexible prosthetic solutions to complex full-arch rehabilitation.


Inaugural GPO Partners include Unified Smiles, the Dentist Entrepreneur Organization (DEO), and Dental Purchasing Partners (DPP)


Growing national network helps patients find local dentists trained to provide oral appliance therapy for obstructive sleep apnea.


Students recently headed back to class for the current academic year, but Texas A&M College of Dentistry is looking ahead as deadlines approach for the dental Class of 2031 and the


Products     22 September 2026

Women in Dentistry Series

Paul Feuerstein sits down with Sandra Hirsch, president, CEO, and co-founder of Zyris.


 
 
 
 

 
 
 
 

Most popular

 
 

Events